Screening for Down Syndrome
- 1 January 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 107 (1) , 11-17
- https://doi.org/10.1097/01.aog.0000190215.67096.90
Abstract
To assess obstetricians' practice patterns and knowledge regarding screening for Down syndrome. A questionnaire was mailed to 1,105 American College of Obstetricians and Gynecologists Fellows and Junior Fellows in 2004. Sixty percent of questionnaires were returned. Statistical analyses were limited to the 532 practicing obstetricians. Greater than 80% felt their training and experience qualified them to counsel patients about genetic issues in pregnancy. However, 45% rated their residency training regarding prenatal diagnosis as barely adequate or nonexistent. American College of Obstetricians and Gynecologists publications were rated by 86% as an important source of information on genetic counseling. Seventy-eight percent of practitioners counsel all obstetric patients about risks for fetal aneuploidy, and 67% provide counseling for heritable genetic abnormalities. Although the majority (99%) offer second-trimester Down syndrome screening, only 55% also offer first-trimester screening for Down syndrome. Almost one half (49%) use the quad screen, and 6% offer integrated first- and second-trimester screening. The majority (88%) routinely offer amniocentesis to patients who are at elevated risk for genetic abnormalities, whereas 44% also offer chorionic villus sampling. Few (2%) perform chorionic villus sampling. Most obstetricians manage patients at risk for fetal genetic abnormalities according to American College of Obstetricians and Gynecologists educational materials. This survey identified deficiencies related to Down syndrome screening, including a limited number of practitioners performing chorionic villus sampling and physicians' own perception that training regarding genetic counseling should be improved. Educational strategies are needed to address these deficiencies before first-trimester screening programs are widely implemented. III.Keywords
This publication has 25 references indexed in Scilit:
- First-Trimester Nasal Bone Evaluation for Aneuploidy in the General PopulationObstetrics & Gynecology, 2004
- Maternal Serum Invasive Trophoblast Antigen (Hyperglycosylated hCG) as a Screening Marker for Down Syndrome during the Second TrimesterClinical Chemistry, 2004
- First- and second-trimester evaluation of risk (faster) trial: principal results of the NICHD multicenter down syndrome screening studyAmerican Journal of Obstetrics and Gynecology, 2003
- First-Trimester Sonographic Screening for Down Syndrome*1Published by Wolters Kluwer Health ,2003
- Executive summaryJournal of Medical Screening, 2003
- Antenatal screening for Down's syndrome with the quadruple testThe Lancet, 2003
- Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosusBJOG: An International Journal of Obstetrics and Gynaecology, 2002
- PRENATAL SCREENING FOR DOWN'S SYNDROME USING INHIBIN-A AS A SERUM MARKERPrenatal Diagnosis, 1996
- An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 1984
- MATERNAL SERUM ALPHA-FETOPROTEIN MEASUREMENT: A SCREENING TEST FOR DOWN SYNDROMEThe Lancet, 1984